IndraLab

Statements


| 1 10

reach
"USP19 Positively Regulates Tumor Growth and Metastasis."

reach
"In vivo experiments showed that USP19 silencing reduces tumorigenicity and delays tumor onset and growth, and the opposite was observed upon wild type USP19 overexpression (but not when overexpressing a catalytically dead mutant, or a cytoplasmic version of USP19)."

reach
"Moreover, the downregulation of USP19 promoted tumor growth in a xenograft model."
| PMC

eidos
"USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression ."

reach
"Also, worth investigating is whether USP19 inhibitors are promising drugs against tumors in general, or only some specific types of tumors, like liver cancers with p53 deletions/mutations that originate in a NAFLD background.In conclusion, this study shows that p53 deletion/mutation increases USP19, which in turn stabilizes SOAT1, increases cholesterol esterification and accelerates tumor progression (Figure 1)."

reach
"USP19 depletion significantly diminished the tumor weight and tumor volume compared with shControl group ( Fig. 6 A–D)."

reach
"Furthermore, the authors of this study also showed that USP19 depletion decreased tumor growth and metastasis in vivo."

reach
"Therefore, anti-tumor or pro-tumor effects mediated by USP19-CY may differ depending on cancer subtype."

reach
"Additionally, USP19 depletion results in significant enrichment of apoptosis and reduces the growth of tumors in the mouse xenograft."

reach
"The results showed that USP19 knockdown suppressed the proliferation, anchorage-independent growth and xenograft tumor formation of DLBCL cells and arrested the cell cycle at the G1 stage."

reach
"They validated their results using in vivo models and observed that USP19 downregulation promoted tumor growth in a xenograft model."